The change in separation of mADL scores started after 14 days, Pahwa said at a late-breaking session at the American Academy of Neurology (AAN) annual meeting.. Improvements in Clinical Global ...

This drug seems to be better than the current D2, D3 agonists,” study investigator Rajesh Pahwa, MD, professor of neurology and director of the Parkinson's Disease and Movement Disorder Center ...

In TEMPO-1, two fixed doses of tavapadon -- 5 mg and 15 mg -- showed lower combined part II and III scores versus placebo, said Rajesh Pahwa, MD, of the University of Kansas Medical Center in ...

Oral treatments currently used for essential tremor are “often unsatisfactory,” according to Rajesh Pahwa, MD, FAAN, Laverne and Joyce Rider Professor of Neurology at the University of Kansas ...

For the TEMPO-1 trial, Rajesh Pahwa, MD, FAAN, Laverne and Joyce Rider Professor of Neurology at the University of Kansas School of Medicine and director of the Movement Disorder Program at the ...

Dr. Rajesh Pahwa, director of the Parkinson's Foundation Center of Excellence at the University of Kansas Medical Center; Tags. Up To Date Podcast Parkinson's Disease disease KU Medical Center ...

SAN FRANCISCO, Nov. 16, 2022 /PRNewswire/ -- Vial welcomes Dr. Rajesh Pahwa as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Pahwa is Chief of the Parkinson ...

The change in separation of mADL scores started after 14 days, Pahwa said at a late-breaking session at the American Academy of Neurology (AAN) annual meeting.. Improvements in Clinical Global ...

SAN FRANCISCO, Nov. 16, 2022 /PRNewswire/ -- Vial welcomes Dr. Rajesh Pahwa as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Pahwa is Chief of the Parkinson ...